Trials / Completed
CompletedNCT00398294
To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)
An Open-Label, Single-Arm, Prospective Study to Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet in Patients With Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0733, simvastatin / Duration of Treatment: 12 Weeks |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2006-04-04
- Completion
- 2006-04-04
- First posted
- 2006-11-10
- Last updated
- 2024-08-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00398294. Inclusion in this directory is not an endorsement.